Cargando…
The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib
Cell lines have been used for drug discovery as useful models of cancers; however, they do not recapitulate cancers faithfully, particularly from the viewpoints of microenvironmental independence. Patient-derived xenografts (PDX) are established by the transfer of primary tumor cells directly from p...
Autores principales: | Morishita, Takanobu, Hayakawa, Fumihiko, Sugimoto, Keiki, Iwase, Mizuho, Yamamoto, Hideyuki, Hirano, Daiki, Kojima, Yuki, Imoto, Naoto, Naoe, Tomoki, Kiyoi, Hitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302911/ https://www.ncbi.nlm.nih.gov/pubmed/27494842 http://dx.doi.org/10.18632/oncotarget.11025 |
Ejemplares similares
-
Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cells
por: Sugimoto, Keiki, et al.
Publicado: (2015) -
Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism
por: Aoki, Tomohiro, et al.
Publicado: (2016) -
Characterization of Perturbing Actions by Verteporfin, a Benzoporphyrin Photosensitizer, on Membrane Ionic Currents
por: Huang, Mei-Han, et al.
Publicado: (2019) -
Dasatinib-based 2-step induction for adults with Philadelphia chromosome–positive acute lymphoblastic leukemia
por: Sugiura, Isamu, et al.
Publicado: (2022) -
De novo diffuse large B-cell lymphoma with a CD20 immunohistochemistry-positive and flow cytometry-negative phenotype: Molecular mechanisms and correlation with rituximab sensitivity
por: Tokunaga, Takashi, et al.
Publicado: (2014)